Fund Evaluator:
Congress SMid Growth ETF (CSMD)Equity
Global Asset Class
U.S. Equity
Fund Group
Mid-Cap Growth
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.68% D
Expense Ratio
$454 Mil
Assets
Open
Status
0.00%
12b-1 Fee
0.00%
TTM Yield
0.00%
Max Load
23%
Portfolio Turnover
Best Performing in Mid-Cap Growth Over the Last Year
| 44.9% | PRIMECAP Odyssey Aggressive Growth (POAGX) |
| 27.1% | Eventide Gilead N (ETGLX) |
| 23.3% | Sit Small Cap Growth (SSMGX) |
| 19.8% | Goldman Sachs Small/Mid Cap Growth Inv (GTMTX) |
| 19.2% | ProFunds Mid Cap Growth Inv (MGPIX) |
Data as of 7/31/2026
-7.6% D
1-Mo Return
3.9% B
3-Mo Return
6.6% C
YTD Return
5.2% D
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Congress
Inception Date
8/21/2023
Share Class Type
Equity Investment Style
Small-Cap
Growth
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
S&P 500 (TR) (1970): 100%
Additional Fund Details
Congress SMid Growth ETF Overview
CSMD Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| CSMD Return (NAV) | -7.6% | 3.9% | 5.2% | na | na | na |
| CSMD Grade | D | B | D | na | na | na |
| +/- Category | -2.1% | 1.8% | -0.3% | na | na | na |
| Mid-Cap Growth Avg | -5.5% | 2.1% | 5.5% | 10.5% | 2.5% | 10.9% |
| CSMD Tax Cost Ratio | na | na | 0.0% | na | na | na |
CSMD Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| CSMD Return (NAV) | 6.6% | 5.7% | 12.6% | na | na | na | na | na | na | na | na |
| CSMD Grade | C | D | F | na | na | na | na | na | na | na | na |
| +/- Category | 0.9% | -0.3% | -4.8% | na | na | na | na | na | na | na | na |
| Mid-Cap Growth Avg | 5.7% | 6.1% | 17.3% | 20.8% | -28.1% | 12.3% | 40.4% | 33.9% | -4.6% | 25.3% | 5.3% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Small-Cap Growth |
| Bond Investment Style: | na |
| Yield: | 0.0% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $454 Mil |
| Fund Total Assets: | $ 454 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 23% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 3.0 years | |||
| Average Tenure: 3.0 years | |||
| Managers (Year): Huynh Nancy (2023), Lagan Daniel (2023) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 49 |
| % in Top 10 Holdings: | 32.1% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 3.6% |
Portfolio Allocation |
|
| Domestic Stock: | 95.5% |
| Foreign Stock: | 3.6% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | -0.1% |
| Cash: | 0.9% |
Purchase Information
| Fund Family: | Congress |
| Phone Number: | 888-688-1299 |
| Website: |
| Status: | Open |
| Inception Date: | August 21, 2023 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | 0.00% |
Expenses and Fees | |
| Expense Ratio (%): | 0.68% ( Rating : Above Avg ) |
| Category Average Expense Ratio (%): | 1.09% |
| Share Class: | Congress SMid Growth ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.